ArticleFrontiers in oncology2021

BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors.

Elizabeth Dudnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.